{"id":6925,"date":"2021-04-14T08:25:46","date_gmt":"2021-04-14T13:25:46","guid":{"rendered":"http:\/\/losperiodistas.com.mx\/portal\/?p=6925"},"modified":"2021-04-14T08:25:47","modified_gmt":"2021-04-14T13:25:47","slug":"la-combinacion-de-dos-anticuerpos-monoclonales-reduce-un-81-la-infeccion-por-covid-19-la-razon","status":"publish","type":"post","link":"https:\/\/losperiodistas.com.mx\/portal\/la-combinacion-de-dos-anticuerpos-monoclonales-reduce-un-81-la-infeccion-por-covid-19-la-razon\/","title":{"rendered":"La combinaci\u00f3n de dos anticuerpos monoclonales reduce un 81% la infecci\u00f3n por Covid-19 | La Raz\u00f3n"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\" style=\"font-size:18px\"><em>La administraci\u00f3n subcut\u00e1nea de los f\u00e1rmacos en investigaci\u00f3n casirivimab e imdevimab logra evitar el contagio entre los contactos domiciliarios de personas infectadas por el SARS-CoV-2<\/em><\/h2>\n\n\n\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"801\" src=\"https:\/\/losperiodistas.com.mx\/portal\/wp-content\/uploads\/2021\/04\/Captura-de-Pantalla-2021-04-14-a-las-8.21.52-1024x801.jpg\" alt=\"\" class=\"wp-image-6926\" srcset=\"https:\/\/losperiodistas.com.mx\/portal\/wp-content\/uploads\/2021\/04\/Captura-de-Pantalla-2021-04-14-a-las-8.21.52-1024x801.jpg 1024w, https:\/\/losperiodistas.com.mx\/portal\/wp-content\/uploads\/2021\/04\/Captura-de-Pantalla-2021-04-14-a-las-8.21.52-300x235.jpg 300w, https:\/\/losperiodistas.com.mx\/portal\/wp-content\/uploads\/2021\/04\/Captura-de-Pantalla-2021-04-14-a-las-8.21.52-768x601.jpg 768w, https:\/\/losperiodistas.com.mx\/portal\/wp-content\/uploads\/2021\/04\/Captura-de-Pantalla-2021-04-14-a-las-8.21.52.jpg 1212w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"has-vivid-cyan-blue-color has-text-color has-medium-font-size\">EVA S. CORADA \/ LA RAZ\u00d3N<\/p>\n\n\n\n<p>Un ensayo cl\u00ednico ha demostrado que la administraci\u00f3n subcut\u00e1nea de casirivimab e imdevimab reduce el riesgo de infecciones sintom\u00e1ticas en un 81% en personas que no estaban infectados cuando entraron en el ensayo. Asimismo, en las personas tratadas con casirivimab e imdevimab que segu\u00edan experimentando una infecci\u00f3n sintom\u00e1tica resolvieron la duraci\u00f3n de los s\u00edntomas en un plazo medio de una semana, en comparaci\u00f3n con las tres semanas en las que hab\u00edan recibido placebo. No se observaron signos nuevos ni graves de seguridad.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Noticias relacionadas<\/h3>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<ul class=\"wp-block-list\"><li><a href=\"https:\/\/www.larazon.es\/salud\/20201104\/hf2pl5qtzrfdrfd646nn7wjcyu.html\">Salud.Anticuerpos monoclonales, \u00bfla nueva esperanza contra el coronavirus?<\/a><\/li><\/ul>\n\n\n\n<p>Tal y como ha se\u00f1alado Levi Garraway, director m\u00e9dico y jefe de Desarrollo Global de Productos de Roche, \u201clos datos de hoy confirman el potencial valor dual de casirivimab e imdevimab para\u00a0<strong>reducir las infecciones por contagios domiciliarios por Covid-19 y disminuir el impacto de la enfermedad en quienes se infectan<\/strong>, cuando se administra por v\u00eda subcut\u00e1nea. Aunque las vacunaciones est\u00e1n aumentando en todo el mundo, sigue habiendo una necesidad no cubierta para prevenir las infecciones y facilitar una protecci\u00f3n inmediata contra la Covid-19 entre los contactos cercanos. Por este motivo, estamos muy satisfechos de aportar estos datos a las autoridades sanitarias con el objetivo de que esta combinaci\u00f3n est\u00e9 disponible para m\u00e1s personas tan pronto como sea posible\u201d.<\/p>\n\n\n\n<p>Este ensayo cl\u00ednico fase III -del Instituto Nacional de Alergias y Enfermedades Infecciosas de EE UU (Niaid, por sus siglas en ingl\u00e9s) y la farmac\u00e9utica Roche- doble ciego y controlado con placebo, evalu\u00f3 el efecto de ambos f\u00e1rmacos en&nbsp;<strong>personas sin anticuerpos frente al SARS-CoV-2 ni s\u00edntomas de Covid-19, que viv\u00edan en el mismo hogar que alguien que s\u00ed hab\u00eda dado positivo<\/strong>&nbsp;en los cuatro d\u00edas anteriores. Incluy\u00f3 1.505 personas que no estaban infectadas con SARS-CoV-2 en situaci\u00f3n basal y recibieron o bien una dosis de casirivimab con imdevimab (1.200 mg) o bien placebo, administrados como inyecciones subcut\u00e1neas.<\/p>\n\n\n\n<p>Asimismo, el estudio que ten\u00eda varias partes evalu\u00f3 la combinaci\u00f3n de anticuerpos en un grupo de\u00a0<strong>204 pacientes asintom\u00e1ticos reci\u00e9n infectados<\/strong>, que de manera aleatoria recibieron una dosis de casirivimab e imdevimab (1.200 mg, mediante administraci\u00f3n subcut\u00e1nea) o placebo. En este grupo, casirivimab e imdevimab<strong>\u00a0redujo en un 31% el riesgo global de progresi\u00f3n a Covid-19 sintom\u00e1tico<\/strong>.<\/p>\n\n\n\n<p>Fuente: https:\/\/www.larazon.es\/salud\/20210414\/inkv4pqva5cubfwco6f5xum5ve.html<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La administraci\u00f3n subcut\u00e1nea de los f\u00e1rmacos en investigaci\u00f3n casirivimab e imdevimab logra evitar el contagio entre los contactos domiciliarios de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":6926,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[8],"tags":[1029],"class_list":["post-6925","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias","tag-casirivimab-e-imdevimab"],"_links":{"self":[{"href":"https:\/\/losperiodistas.com.mx\/portal\/wp-json\/wp\/v2\/posts\/6925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/losperiodistas.com.mx\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/losperiodistas.com.mx\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/losperiodistas.com.mx\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/losperiodistas.com.mx\/portal\/wp-json\/wp\/v2\/comments?post=6925"}],"version-history":[{"count":1,"href":"https:\/\/losperiodistas.com.mx\/portal\/wp-json\/wp\/v2\/posts\/6925\/revisions"}],"predecessor-version":[{"id":6927,"href":"https:\/\/losperiodistas.com.mx\/portal\/wp-json\/wp\/v2\/posts\/6925\/revisions\/6927"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/losperiodistas.com.mx\/portal\/wp-json\/wp\/v2\/media\/6926"}],"wp:attachment":[{"href":"https:\/\/losperiodistas.com.mx\/portal\/wp-json\/wp\/v2\/media?parent=6925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/losperiodistas.com.mx\/portal\/wp-json\/wp\/v2\/categories?post=6925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/losperiodistas.com.mx\/portal\/wp-json\/wp\/v2\/tags?post=6925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}